Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

  • Generic hydralazine now availableSubscription

    Generic hydralazine tablets 25mg and hydralazine powder for concentrate for solution for injection or infusion 20mg/ml will replace the brand Apresoline from Amdipharm Mercury with immediate effect.

  • Side effects and interactions for FarestonSubscription

    The summary of product characteristics (SPC) for Fareston (toremifene; Orion) now states that cases of liver injury, including elevation of liver enzymes, hepatitis and jaundice, have been reported with toremifene. Additionally, the amount of lactose per tablet has been amended from 30mg to 28.5mg. The updated SPC also states that, theoretically, the metabolism of toremifene is inhibited by drugs known to inhibit the CYP3A enzyme system. Examples of such drugs are antifungal imidazoles, ...

  • Reduced shelf life for CaystonSubscription

    The shelf life for Cayston (aztreonam) solvent ampoule has been reduced from four to three years. 

  • Extra needle in ZypadheraSubscription

    According to the updated summary of characteristics for Zypadhera (olanzapine pamoate monohydrate; Eli Lilly), the product now comes with two 19-gauge, 50mm hypodermic safety needles.

Other product updates

  • NICE recommends LixianaSubscription

    The National Institute for Health and Care Excellence (NICE) has recommended edoxaban (Lixiana; Daiichi Sankyo) as an option for preventing stroke and systemic embolism in adults with non-valvular atrial fibrillation who have one or more further risk factors in final guidance. The guidance is available from the NICE website.

  • Community pharmacy flu serviceSubscription

    Community pharmacies can now start offering the seasonal influenza vaccine service, as part of the 2015–2016 pharmacy funding contract. Prior to commencing this advanced service, community pharmacies must complete the notification form on the NHS Business Services Authority website that informs NHS England of the pharmacy’s intention to provide ...

  • Abraxane rejected by NICESubscription

    The National Institute for Health and Care Excellence (NICE) has issued final draft guidance that does not recommend Abraxane (nab-paclitaxel; Celgene) for the treatment of metastatic, previously untreated pancreatic adenocarcinoma. This decision has been made on the grounds that there is minimal benefit to the patient compared with existing treatments so the cost is not justified. Consultees have two weeks to notify NICE of any factual ...

  • September 2015: SMC decisionsSubscription

    The Scottish Medicines Consortium (SMC) has accepted the following medicines for NHS Scotland for particular indications: aflibercept (Eylea; Bayer); bortezomib (Velcade; Janssen-Cilag); ledipasvir/sofosbuvir (Harvoni; Gilead); lisdexamfetamine (Elvanse; Shire); pasireotide (Signifor; Novartis); sitagliptin (Januvia; Merck Sharp & Dohme). Bevacizumab (Avastin; Roche) has been accepted for restricted use in combination with pacitaxel ...

Other notifications

  • Pictogram software available from FIPSubscription

    The International Pharmaceutical Federation (FIP) has published an Arabic version of its pictogram software to help pharmacists explain to refugees how to take their medicines. The pictogram software is available from the FIP website.

  • Workshops on Parkinson's diseaseSubscription

    The Centre for Pharmacy Postgraduate Education (CPPE) has launched a new “focal point” programme on Parkinson’s disease for pharmacy teams. Workshops will be held across England starting from October 2015. The workshops are free for NHS staff. More information can be found on the CPPE ...

  • Public health resourceSubscription

    Public Health England has created a new online resource for public health professionals called ‘Health Matters’. It contains information about important public health challenges, including evidence based actions to address ...

  • NHS Atlas of Variation 2015 publishedSubscription

    The latest NHS Atlas of Variation, launched by Public Health England, NHS Right Care and NHS England, is now available to download from the NHS Right Care website. The atlas is made up of a series of maps that indicate the difference in the provision of care across England. 

Other resources

  • EPS workshops for community pharmaciesSubscription

    The Health and Social Care Information Centre (HSCIC) is running training events about the electronic prescription service (EPS) for all staff working in community pharmacy and for dispensing appliance contractors in England. There will be at least seven training sessions in each local pharmaceutical committee (LPC) area, covering each of the patient medication record (PMR) systems: Analyst; CoMPaSS; NexPhase; Pharmacy Manager; ProScript; ProScript LINK; Rx Webb. The Pharmaceutical ...

  • Peer discussion online workshopSubscription

    Every pharmacist and pharmacy technician in England, Scotland and Wales will be invited by the General Pharmaceutical Council (GPhC) to join an online workshop to share, discuss and identify the best approaches to peer discussion that they can use when reflecting on their practice. The workshop will take place in September 2015 and the number of places is limited so access will be granted on a first-come first-serve basis. All ...

Other opportunities

  • Consultation on Crohn's disease testsSubscription

    The National Institute of Health and Care Excellence (NICE) has published draft guidance on new tests to help guide treatment for people with Crohn’s disease. The guidance says further research is needed before the tests can be recommended for routine use in the NHS.

  • Consultation on myeloma careSubscription

    The National Institute for Health and Care Excellence (NICE) has published draft guidance for consultation on the care of adults suffering from myeloma. It complements existing NICE guidance on the drug treatment of myeloma. Views on the draft guideline can be submitted until 1 October 2015. More information can be found on the NICE website. 

  • NICE consults on recommendations for hepatitis C medicinesSubscription

    The National Institute for Health and Care Excellence (NICE) has published draft guidance recommending daclatasvir (Daklinza; Bristol Myers-Squibb),

  • Immunosuppressive therapy for kidney transplantation guidanceSubscription

    The National Institute for Health and Care Excellence (NICE) has published two pieces of draft guidance that will update previous recommendations on immunosuppressive therapy for kidney transplantation in adults and

Other consultations

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free newsletters.

Pharmaceutical Journal Jobs

More jobs